{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:09:10Z","timestamp":1792008550762,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.brainresbull.2022.08.022","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:29:06Z","timestamp":1661650146000},"page":"163-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats"],"prefix":"10.1016","volume":"189","author":[{"given":"Brianna","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Stoltzfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Nyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Freet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Grigson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00125-001-0719-z","article-title":"The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men","volume":"45","author":"Agers\u00f8","year":"2002","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(99)00133-5","article-title":"Persistent increase in the motivation to take heroin in rats with a history of drug escalation","volume":"22","author":"Ahmed","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib4","first-page":"20","article-title":"Addiction as an artificially induced instinct. A theory","volume":"85","author":"Bejerot","year":"1971","journal-title":"Nord Med."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102121","article-title":"Sublingual buprenorphine-naloxone precipitated withdrawal-A case report with review of literature and clinical considerations","volume":"53","author":"Bhatia","year":"2020","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.08.022_bib6","first-page":"235","article-title":"Diurnal rhythms in plasma glucose, insulin, growth hormone and melatonin levels in fasted and hyperglycaemic rats","volume":"24","author":"Bizot-Espiard","year":"1998","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib7","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J. Endocrinol."},{"issue":"7 Suppl A","key":"10.1016\/j.brainresbull.2022.08.022_bib8","first-page":"S2","article-title":"What are incretins, and how will they influence the management of type 2 diabetes?","volume":"12","author":"Blonde","year":"2006","journal-title":"J. Manag Care Pharm."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib9","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0443-18.2019","article-title":"Glucagon-like peptide-1 receptor agonist treatment does not reduce abuse-related effects of opioid drugs","volume":"6","author":"Bornebusch","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib10","unstructured":"Bunce S. Use of a GLP-1R Agonist to Treat Opioid Use Disorder. 2021 Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04199728?term=Bunce&draw=2&rank=1. NLM identifier: NCT04199728."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib11","first-page":"212","article-title":"Measurement and extinction of conditioned withdrawal-like responses in opiate-dependent patients","volume":"49","author":"Childress","year":"1984","journal-title":"NIDA Res Monogr."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/a0036264","article-title":"Once is too much: conditioned aversion develops immediately and predicts future cocaine self-administration behavior in rats","volume":"128","author":"Colechio","year":"2014","journal-title":"Behav. Neurosci."},{"issue":"11","key":"10.1016\/j.brainresbull.2022.08.022_bib13","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1046\/j.1460-9568.1998.00368.x","article-title":"Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization","volume":"10","author":"De Vries","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"14","key":"10.1016\/j.brainresbull.2022.08.022_bib14","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.08.022_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/FBP.0000000000000685","article-title":"Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin seeking in rats","volume":"33","author":"Douton","year":"2022","journal-title":"Behav. Pharm."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FBP.0000000000000609","article-title":"Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats","volume":"32","author":"Douton","year":"2021","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13117","article-title":"Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats","volume":"27","author":"Douton","year":"2022","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib18","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1152\/ajpendo.2001.281.1.E155","article-title":"Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers","volume":"281","author":"Edwards","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.08.022_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.022_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077284","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1042\/BST20150244","article-title":"The complexity of signalling mediated by the glucagon-like peptide-1 receptor","volume":"44","author":"Fletcher","year":"2016","journal-title":"Biochem Soc. Trans."},{"issue":"9","key":"10.1016\/j.brainresbull.2022.08.022_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/mp.2012.141","article-title":"GLP-1 analog attenuates cocaine reward","volume":"18","author":"Graham","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ddmod.2009.03.005","article-title":"Reward Comparison: The Achilles' heel and hope for addiction","volume":"5","author":"Grigson","year":"2008","journal-title":"Drug Disco Today Dis. Models"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1037\/0735-7044.116.2.321","article-title":"Cocaine-induced suppression of saccharin intake: a model of drug- induced devaluation of natural rewards","volume":"116","author":"Grigson","year":"2002","journal-title":"Behav. Neurosci."},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.022_bib25","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41386-018-0010-3","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats","volume":"43","author":"Hernandez","year":"2018","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib27","first-page":"26","article-title":"Exposure to environmental enrichment attenuates addiction-like behavior and alters molecular effects of heroin self-administration in rats","volume":"139","author":"Imperio","year":"2018"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib28","article-title":"Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia","volume":"14","author":"Ja'arah","year":"2021","journal-title":"Clin. Med Insights Endocrinol. Diabetes"},{"issue":"6","key":"10.1016\/j.brainresbull.2022.08.022_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1463-1326.2012.01557.x","article-title":"Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight","volume":"14","author":"Jelsing","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0031-9384(97)00493-9","article-title":"Circadian control of insulin secretion is independent of the temporal distribution of feeding","volume":"63","author":"Kalsbeek","year":"1998","journal-title":"Physiol. Behav."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.08.022_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4093\/dmj.2016.40.5.365","article-title":"Blood glucose measurement: is serum equal to plasma?","volume":"40","author":"Kim","year":"2016","journal-title":"Diabetes Metab. J."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3727\/096368916X692258","article-title":"Diabetes in rats is cured by islet transplantation\u2026but only during daytime","volume":"26","author":"King","year":"2017","journal-title":"Cell Transpl."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib33","first-page":"6163","article-title":"CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors","volume":"23","author":"Kinzig","year":"2003"},{"issue":"4879","key":"10.1016\/j.brainresbull.2022.08.022_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.brainresbull.2022.08.022_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pbb.2008.03.018","article-title":"Heroin self-administration: I. Incubation of goal-directed behavior in rats","volume":"90","author":"Kuntz","year":"2008","journal-title":"Pharm. Biochem Behav."},{"issue":"10118","key":"10.1016\/j.brainresbull.2022.08.022_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.brainresbull.2022.08.022_bib37","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/mp.2017.187","article-title":"Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight","volume":"23","author":"Lopez-Ferreras","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"18","key":"10.1016\/j.brainresbull.2022.08.022_bib38","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined","volume":"384","author":"Lundgren","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"30","key":"10.1016\/j.brainresbull.2022.08.022_bib39","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1523\/JNEUROSCI.3464-14.2015","article-title":"Negative Energy Balance Blocks Neural and Behavioral Responses to Acute Stress by \"Silencing\" Central Glucagon-Like Peptide 1 Signaling in Rats","volume":"35","author":"Maniscalco","year":"2015","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.022_bib40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jne.12086","article-title":"Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats","volume":"25","author":"McKay","year":"2013","journal-title":"J. Neuroendocr."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. The","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J. Comp. Neurol."},{"issue":"11","key":"10.1016\/j.brainresbull.2022.08.022_bib42","doi-asserted-by":"crossref","first-page":"E1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib43","unstructured":"National Institute on Drug Abuse. (2014). Drug Facts: Heroin. Bethesda, MD: National Institute on Drug Abuse. Available at \u3008http:\/\/www.drugabuse.gov\/publications\/drugfacts\/heroin\u3009."},{"issue":"4282","key":"10.1016\/j.brainresbull.2022.08.022_bib44","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.841320","article-title":"Conditioned narcotic withdrawal in humans","volume":"195","author":"O'Brien","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib45","unstructured":"Olsen, M.N., Fields, C., Grigson, P.S. Glucagon-like peptide-1 receptor agonist, exendin-4, pretreatment decreases aversive taste reactivity to naloxone-induced opioid withdrawal in rats. in preparation."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib46","unstructured":"Pandemic and Policy Options to Move Forward. To the Point: Commonwealth Fund; 2021 Available from: https:\/\/doi.org\/10.26099\/gyf5\u20133z49."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.022_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/add.13193","article-title":"Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England","volume":"111","author":"Pierce","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib48","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212283","article-title":"A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond","volume":"4","author":"Prasad-Reddy","year":"2015","journal-title":"Drugs Context"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/FBP.0b013e32834eb060","article-title":"Environmental enrichment protects against the acquisition of cocaine self-administration in adult male rats, but does not eliminate avoidance of a drug-associated saccharin cue","volume":"23","author":"Puhl","year":"2012","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2013.04.010","article-title":"A novel model of chronic sleep restriction reveals an increase in the perceived incentive reward value of cocaine in high drug-taking rats","volume":"109","author":"Puhl","year":"2013","journal-title":"Pharm. Biochem Behav."},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.022_bib51","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.2337\/db12-1543","article-title":"Consequences of exposure to light at night on the pancreatic islet circadian clock and function in rats","volume":"62","author":"Qian","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainresbull.2022.08.022_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0119034","article-title":"Activation of the GLP-1 receptors in the nucleusof the solitary tract reduces food reward behavior and targets themesolimbic system","volume":"10","author":"Richard","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.03.059","article-title":"Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure","volume":"1350","author":"Rinaman","year":"2010","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.brainresbull.2022.08.022_bib55","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.08.022_bib56","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1210\/jc.2017-00199","article-title":"Tolerance does not develop toward liraglutide's glucose-lowering effect","volume":"102","author":"Sedman","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173443","article-title":"Tolerance develops toward GLP-1 receptor agonists' glucose-lowering effect in mice","volume":"885","author":"Sedman","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12977","article-title":"The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder","volume":"26","author":"Shi","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","article-title":"The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice","volume":"149","author":"Sorensen","year":"2015","journal-title":"Physiol. Behav."},{"issue":"11","key":"10.1016\/j.brainresbull.2022.08.022_bib60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archpsyc.55.11.967","article-title":"Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities","volume":"55","author":"Tsuang","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6560","key":"10.1016\/j.brainresbull.2022.08.022_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib62","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1037\/a0016498","article-title":"Yoked delivery of cocaine is aversive and protects against the motivation for drug in rats","volume":"123","author":"Twining","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib63","doi-asserted-by":"crossref","unstructured":"Urbanik L.A., Acharya N., and Grigson P.S. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats. submitted for publication to Brain Research Bulletin on May 2, 2022.","DOI":"10.1016\/j.brainresbull.2022.08.023"},{"key":"10.1016\/j.brainresbull.2022.08.022_bib64","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","author":"Varshneya","year":"2021","journal-title":"J. Addict. Med"},{"issue":"5","key":"10.1016\/j.brainresbull.2022.08.022_bib65","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.022_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10550490252801620","article-title":"A family study of the high-risk children of opioid- and alcohol-dependent parents","volume":"11","author":"Wilens","year":"2002","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105715","article-title":"antidiabetic medications and risk of depression - a population-based cohort and nested case-control study","volume":"140","author":"Wium-Andersen","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.brainresbull.2022.08.022_bib68","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4314\/ahs.v19i3.35","article-title":"The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"Afr. Health Sci."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.08.022_bib69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41386-019-0531-4","article-title":"Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats","volume":"45","author":"Zhang","year":"2020","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2022.08.022_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108599","article-title":"A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats","volume":"192","author":"Zhang","year":"2021","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.022_bib71","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00213-008-1414-2","article-title":"Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse","volume":"203","author":"Zhou","year":"2009","journal-title":"Psychopharmacol. (Berl. )"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:52:43Z","timestamp":1759783963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923022002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":71,"alternative-id":["S0361923022002210"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.08.022","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}